Vident Investment Advisory, LLC - BEAM THERAPEUTICS INC ownership

BEAM THERAPEUTICS INC's ticker is BEAM and the CUSIP is 07373V105. A total of 196 filers reported holding BEAM THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 1.13 and the average weighting 0.3%.

Quarter-by-quarter ownership
Vident Investment Advisory, LLC ownership history of BEAM THERAPEUTICS INC
ValueSharesWeighting
Q2 2023$357,655
-1.5%
11,205
-5.5%
0.01%0.0%
Q1 2023$363,061
+9.0%
11,857
+39.2%
0.01%
-7.7%
Q4 2022$333,218
+59.4%
8,520
+4.2%
0.01%
+85.7%
Q3 2022$209,000
-1.4%
8,177
+47.4%
0.01%
+16.7%
Q2 2022$212,000
-23.2%
5,548
+15.0%
0.01%
-14.3%
Q1 2022$276,000
-32.8%
4,825
-6.5%
0.01%
-36.4%
Q4 2021$411,000
+30.1%
5,160
+110.4%
0.01%
+10.0%
Q2 2021$316,0002,4530.01%
Other shareholders
BEAM THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
MWG Management Ltd. 2,362,635$304,095,00029.88%
UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO 224,391$28,881,00022.15%
HSG Holding Ltd 796,089$102,465,0007.14%
DC Investments Management, LLC 21,010$2,704,0006.36%
PATHWAY CAPITAL MANAGEMENT, LP 112,197$14,441,0005.74%
Redmile Group, LLC 2,052,506$264,178,0003.91%
Casdin Capital, LLC 818,820$105,390,0002.68%
Darwin Global Management, Ltd. 126,985$16,344,0002.64%
Evolutionary Tree Capital Management, LLC 44,032$5,667,0002.61%
HHLR ADVISORS, LTD. 1,845,753$237,567,0002.44%
View complete list of BEAM THERAPEUTICS INC shareholders